Do Guidelines Preclude Hepatitis B Patients from Receiving Treatment?

被引：6
|
作者：
Degertekin, Bulent [1 ]
Lok, Anna S. [1 ]
机构：
[1] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA
来源：
HEPATOLOGY | 2009年 / 49卷 / 02期
关键词：
LAMIVUDINE;
D O I：
10.1002/hep.22722
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：700 / 701
页数：2
相关论文
共 50 条
  • [41] Alteration in Hepatitis B Serology in Children Receiving Chemotherapy
    Cam, Sebahat
    Yoruk, Mustafa Asim
    VIRAL IMMUNOLOGY, 2020, 33 (10) : 628 - 633
  • [42] Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B
    Nguyen, M. H.
    Garcia, R. T.
    Trinh, H. N.
    Nguyen, H. A.
    Nguyen, K. K.
    Nguyen, L. H.
    Levitt, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (11-12) : 1150 - 1158
  • [43] Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy
    Fidan, Sami
    Fidan, Evren
    Alandag, Celal
    Erkut, Murat
    Cosar, Arif Mansur
    ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (12) : 835 - 841
  • [44] Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Buti, Maria
    Goulis, John
    Arends, Pauline
    Sypsa, Vana
    Manolakopoulos, Spilios
    Mangia, Giampaolo
    Gatselis, Nikolaos
    Keskin, Onur
    Savvidou, Savvoula
    Hansen, Bettina E.
    Papaioannou, Christos
    Galanis, Kostantinos
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L. A.
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2015, 62 (02) : 363 - 370
  • [45] Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy
    Leaw, SJ
    Yen, CJ
    Huang, WT
    Chen, TY
    Su, WC
    Tsao, CJ
    ANNALS OF HEMATOLOGY, 2004, 83 (05) : 270 - 275
  • [46] In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue
    Mak, Lung-Yi
    Liu, Sze-Hang
    Yap, Desmond Yat-Hin
    Seto, Wai-Kay
    Wong, Danny Ka-Ho
    Fung, James
    Chan, Tak-Mao
    Lai, Ching-Lung
    Yuen, Man-Fung
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (12) : 3630 - 3641
  • [47] Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients
    Wang, Chia-Chi
    Liu, Chun-Jen
    Lai, Ming-Yang
    Kao, Jia-Horng
    Chen, Ding-Shinn
    LIVER INTERNATIONAL, 2007, 27 (02) : 235 - 239
  • [48] Assessment of Current Criteria for Primary Nonresponse in Chronic Hepatitis B Patients Receiving Entecavir Therapy
    Yang, Young-Joo
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    HEPATOLOGY, 2014, 59 (04) : 1303 - 1310
  • [49] Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy
    Shiang Jiin Leaw
    Chia Jui Yen
    Wen Tsung Huang
    Tsai Yun Chen
    Wu Chou Su
    Chao Jung Tsao
    Annals of Hematology, 2004, 83 : 270 - 275
  • [50] Use of hepatitis B vaccine for the treatment of chronic hepatitis B
    Ishikawa, Tetsuya
    Kakumu, Shinichi
    HEPATOLOGY RESEARCH, 2007, 37 : S347 - S350
12345